Applied DNA and Takis Biotech Expand COVID-19 Vaccine Development Program to Include 5th Candidate - Applied DNA Sciences
Applied DNA Sciences Subsidiary, LineaRx, and Takis Biotech Collaborate for Development of a Linear DNA Vaccine Candidate Against Wuhan Coronavirus 2019-nCoV | Business Wire
Applied DNA Sciences (NASDAQ: APDN) Updates on COVID-19 Collaboration with Takis Biotech, 4 Preclinical LinearDNA™ Vaccine Candidates Designed - Applied DNA Sciences
Home
Applied DNA, Takis Biotech Partner To Design COVID-19 Vaccines For Animal Testing
8 Biotechs With Coronavirus Vaccines In Development
Applied DNA Sciences Subsidiary, LineaRx, and Takis Biotech Collaborate for Development of a Linear DNA Vaccine Candidate Against Wuhan Coronavirus 2019-nCoV - Applied DNA Sciences
Applied DNA COVID-19 Collaboration Partner Takis Biotech Receives Italy Ministry of Health Approval to Begin Testing of a Vaccine Candidate on Pre-Clinical Models - Applied DNA Sciences
Coronavirus outbreak: Top coronavirus drugs and vaccines in development
Pathogens | Free Full-Text | A Summary of the SARS-CoV-2 Vaccines and Technologies Available or under Development | HTML
The Domestic Sector - Italy Life Sciences 2021
3 Biotech Stocks Join the Coronavirus Fight | Nasdaq
3 Biotech Stocks Join the Coronavirus Fight | Nasdaq
Potential coronavirus vaccine candidate discovered by Italian researchers
Applied DNA Sciences, Takis Biotech design Covid-19 vaccine candidates
Biopharma's role in tackling coronavirus | Evaluate
Home
2 March 2020 - Applied DNA Sciences Updates on COVID-19 Collaboration with Takis Biotech, 4 Preclinical LinearDNA™ Vaccine Candidates Designed
Coronavirus outbreak: Top coronavirus drugs and vaccines in development
Coronavirus, vaccino italiano con l'accordo Takis-Rottapharm - Il Sole 24 ORE
Home
The Daily Biotech Pulse: 2 IPOs, Nabriva Pneumonia Drug Gets Canadian Regulatory Nod, PhaseBio Doses First COVID-19 Trial Patient
The pandemic pipeline
3 Biotech Stocks Join the Coronavirus Fight | Nasdaq
COVID-eVax, an electroporated plasmid DNA vaccine candidate encoding the SARS-CoV-2 Receptor Binding Domain, elicits protective immune responses in animal models of COVID-19 | bioRxiv
Italian company designs anti-omicron COVID-19 vaccine | Arab News
